Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Induction Regimen Incorporating Topotecan for Treatment of Newly Diagnosed High Risk Neuroblastoma

NCT00070200 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00070200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Induction Regimen Incorporating Topotecan for Treatment of Newly Diagnosed High Risk Neuroblastoma
Lead sponsor
Children's Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2004
Completion date
December 31, 2013
Enrollment
31 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma